Browsing: Pharma

Eli Lilly has investments in China, Japan, and South Korea. Pfizer has become obese thanks…

During their quarterly conference call, Legend Biotech executives expressed little concern about new threats to…

While much of the company’s recent focus remains on strengthening U.S. infrastructure, Eli Lilly has…

The FDA is retiring the old and introducing a new one, announcing a new adverse…

It’s hard to say exactly what the future holds for mass compounding of GLP-1, but…

The rare disease field is undergoing a period of great upheaval, caught between a fickle…

Twelve months ago, drugmakers were hurtling toward 2025, fueled by a year of strong growth…

With an impressive victory over blockbuster products in three head-to-head psoriasis clinical trials, UCB’s Bimzelx…

As many drug companies tally their CEO compensation for 2025, another major drug executive has…

Skyhawk Therapeutics has appointed Aaron Debs as chief commercial officer, securing the expertise of the…